Telehealth Delivered Home-based Walking for Veterans with Peripheral Artery Disease

This study is for Veterans with peripheral artery disease (PAD), a condition where narrowed arteries reduce blood flow to your limbs. It's testing two ways to deliver a home-based walking program: through the internet or through telehealth (video calls with a study coordinator). Both programs include step-count goals, walking tips, and progress tracking for 12 weeks. The goal is to see if these programs can help you walk longer distances and improve your quality of life. You might be eligible if you're a man or woman with PAD, experience leg pain when walking (claudication), can walk at least one city block, and are generally inactive. The study aims to enroll 225 participants.

Study design
This study is an interventional, randomized trial involving 225 Veterans. Participants will be assigned to either an internet-based walking program, a telehealth-based walking program, or usual care.
What's involved
Participants will engage in a walking program for 12 weeks, either through internet pages or telehealth sessions. Some participants may be re-randomized for a second 12-week period.
Compensation
Not stated in the trial record.
Follow-up
The primary outcome, change in maximal walking distance, will be measured at 12 weeks. Some improvements will also be sustained at 24 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06033924

Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

Recruiting
NAAges 21+InterventionalSupportive care
VA Office of Research and Development
~225 participants
Updated 2026-05-06 on ClinicalTrials.gov
What's tested:Walking Program: Internet-basedWalking Program: Telehealth-based

At a glance

Recruiting sites
1 of 3 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in maximal walking distance
Measured over baseline to 12 weeks
Peripheral Artery Disease
3 sites across 3 states
Alabama1
California1
Colorado1
  • Elizabeth A Jackson, MD · PRINCIPAL_INVESTIGATOR · Birmingham VA Medical Center, Birmingham, AL

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Men and women
Diagnosis of lower extremity PAD due to atherosclerosis
Claudication with walking defined as stage 1-3 on the Rutherford Scale
Medical clearance from the patient's primary care provider or vascular care provider
Ability to walk at least one city block
Self-reported sedentary behaviors defined as \< 150 minutes per week of physical activity
Access to a phone and/or email \& Internet
Competent to provide informed consent

Exclusion

Life expectancy of less than six months
Comorbidities that limit walking to a severe degree (i.e., wheelchair-bound)
Resident of a nursing home
Recent enrollment in an exercise program or performing 150 minutes per week or more of exercise
Planned revascularization or amputation in the next two months
Recent CVD events (\< 3 months) including stroke/TIA, MI, UA, PCI/CABG
Unstable cardiac conditions (severe valve disease, NYHA class III-IV heart failure, untreated complex congenital heart disease, or complex arrhythmias)
Current substance abuse
Psychiatric disorder which limits the patient's ability to follow the study protocol
Pregnancy
Inability to speak and read English
  • Change in maximal walking distancebaseline to 12 weeks

    measured using the Gardener-Sinner protocol treadmill test, a validated protocol for measuring maximal and claudication free walking distance among patients with PAD, used in clinical care